Bipin N. Savani spends much of his time researching Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Immunology. His Transplantation study combines topics from a wide range of disciplines, such as Leukemia, Incidence, Disease and Intensive care medicine. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His Hematopoietic stem cell transplantation research includes elements of Hematopoietic stem cell, Transplantation Conditioning, Survival analysis and Melphalan. His work carried out in the field of Surgery brings together such families of science as Odds ratio, Cohort and Hazard ratio. The Immunology study combines topics in areas such as Progenitor cell and Cytotoxic T cell.
His primary areas of study are Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Oncology and Immunology. He mostly deals with Graft-versus-host disease in his studies of Transplantation. His research integrates issues of Gastroenterology and Surgery in his study of Internal medicine.
His Surgery research incorporates elements of Pulmonary function testing and Cohort. His Hematopoietic stem cell transplantation research integrates issues from Hematology, Retrospective cohort study, Cumulative incidence, Hazard ratio and Transplantation Conditioning. His Oncology research incorporates themes from Chemotherapy, Young adult, Minimal residual disease, Lymphoma and Multiple myeloma.
His primary areas of investigation include Internal medicine, Transplantation, Oncology, Hematopoietic cell and Acute leukemia. Bone marrow is closely connected to Gastroenterology in his research, which is encompassed under the umbrella topic of Internal medicine. Bipin N. Savani interconnects Total body irradiation, Leukemia and Disease in the investigation of issues within Transplantation.
Bipin N. Savani works mostly in the field of Disease, limiting it down to concerns involving Immunology and, occasionally, Reduction. His Oncology study incorporates themes from Chemotherapy, Hematology, Proportional hazards model, Haploidentical Donor and Comorbidity index. In his study, Survival rate is inextricably linked to Retrospective cohort study, which falls within the broad field of Acute leukemia.
His scientific interests lie mostly in Internal medicine, Transplantation, Oncology, Myeloid leukemia and Acute leukemia. Internal medicine is closely attributed to Gastroenterology in his research. Bipin N. Savani is involved in the study of Transplantation that focuses on Graft-versus-host disease in particular.
The Oncology study combines topics in areas such as Maintenance therapy, Chemotherapy, Secondary Acute Myeloid Leukemia, Myeloid and Minimal residual disease. His Myeloid leukemia research focuses on Regimen and how it connects with Univariate analysis, ThioTEPA, Treosulfan, Fludarabine and Clofarabine. His Acute leukemia research is multidisciplinary, incorporating elements of Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2 and Outbreak, 2019-20 coronavirus outbreak.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.
Paul J. Martin;J. Douglas Rizzo;John R. Wingard;Karen Ballen.
Biology of Blood and Marrow Transplantation (2012)
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.
Katayoun Rezvani;Stephan Mielke;Mojgan Ahmadzadeh;Yasemin Kilical.
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.
Katayoun Rezvani;Agnes S.M. Yong;Stephan Mielke;Bipin N. Savani.
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Navneet S. Majhail;Stephanie H. Farnia;Paul A. Carpenter;Richard E. Champlin.
Biology of Blood and Marrow Transplantation (2015)
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
M. Mohty;F. Malard;M. Abecassis;E. Aerts.
Bone Marrow Transplantation (2016)
Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis
Pierre Teira;Minoo Battiwalla;Muthalagu Ramanathan;A. John Barrett.
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai;Mukta Arora;Tao Wang;Stephen R. Spellman.
Biology of Blood and Marrow Transplantation (2015)
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
Nilanjan Ghosh;Reem Karmali;Vanderson Rocha;Kwang Woo Ahn.
Journal of Clinical Oncology (2016)
Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia
Katayoun Rezvani;Agnes S. M. Yong;Bipin N. Savani;Stephan Mielke.
Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia
B N Savani;S Mielke;S Adams;M Uribe.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: